{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:22:26Z","timestamp":1793226146773,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejmech.2024.116213","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T08:51:46Z","timestamp":1708073506000},"page":"116213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Carbazole to indolazepinone scaffold morphing leads to potent cell-active dengue antivirals"],"prefix":"10.1016","volume":"268","author":[{"given":"Vasiliki","family":"Zogali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kiousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Voutyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Kalyva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maharah Binte","family":"Abdul Mahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Bist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitti Wing","family":"Ki Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash G.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8937-4986","authenticated-orcid":false,"given":"Gerasimos","family":"Rassias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116213_bib1","volume":"2012","author":"WHO","year":"2012"},{"key":"10.1016\/j.ejmech.2024.116213_bib2","series-title":"Dengue and Dengue Hemorrhagic Fever","year":"2014"},{"key":"10.1016\/j.ejmech.2024.116213_bib3","series-title":"Neglected Tropical Diseases: Drug Discovery and Development","author":"Swinney","year":"2019"},{"key":"10.1016\/j.ejmech.2024.116213_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116213_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1473-3099(18)30023-9","article-title":"The dengue vaccine dilemma","volume":"18","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116213_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.572681","article-title":"Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine","volume":"10","author":"Shukla","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116213_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jclinepi.2017.11.019","article-title":"Controversy and debate on dengue vaccine series-paper 1. Review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs","volume":"95","author":"Dans","year":"2018","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ejmech.2024.116213_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep29201","article-title":"Antibody-dependent enhancement of dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses","volume":"6","author":"Flipse","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116213_bib9","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1021\/acs.chemrev.7b00719","article-title":"Biochemistry and molecular biology of flaviviruses","volume":"118","author":"Barrows","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.116213_bib10","doi-asserted-by":"crossref","first-page":"11348","DOI":"10.1021\/cr500233q","article-title":"Biochemistry and medicinal chemistry of the dengue virus protease","volume":"114","author":"Nitsche","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.116213_bib11","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1021\/acs.jmedchem.5b01653","article-title":"The medicinal chemistry of dengue virus","volume":"59","author":"Behnam","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B\u2013NS3 protease\u2013helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2024.116213_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114753","article-title":"Recent two-year advances in anti-dengue small-molecule inhibitors","volume":"243","author":"Yang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2019.05.010","article-title":"Recent update on anti-dengue drug discovery","volume":"176","author":"Dighe","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","article-title":"Peptide\u2013boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology","volume":"60","author":"Nitsche","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/pathogens11030293","article-title":"Antiviral agents against flavivirus protease: prospect and future direction","volume":"11","author":"Samrat","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2024.116213_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115227","article-title":"N-sulfonyl peptide-hybrids as a new class of dengue virus protease inhibitors","volume":"251","author":"Behrouz","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib18","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1021\/acs.jmedchem.0c02042","article-title":"Beyond basicity: discovery of nonbasic DENV-2 protease inhibitors with potent activity in cell culture","volume":"64","author":"K\u00fchl","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib19","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jacs.9b02505","article-title":"Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of flavivirus NS2B-NS3 protease","volume":"141","author":"Yao","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116213_bib20","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1021\/acs.jmedchem.0c02070","article-title":"Synthesis, structure\u2013activity relationships, and antiviral activity of allosteric inhibitors of flavivirus NS2B\u2013NS3 protease","volume":"64","author":"Nie","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113767","article-title":"Synthesis, structure-activity relationship and antiviral activity of indole- containing inhibitors of Flavivirus NS2B-NS3 protease","volume":"225","author":"Nie","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejmech.2019.07.007","article-title":"Cell- active carbazole derivatives as inhibitors of the zika virus protease","volume":"180","author":"Rassias","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113695","article-title":"Amidoxime prodrugs convert to potent cell-active multimodal inhibitors of the dengue virus protease","volume":"224","author":"Swarbrick","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116213_bib24","unstructured":"Swiss Institute of Bioinformatics, SwissADME, n.d. http:\/\/www.swissadme.ch\/(accessed September 5, 2023).."},{"key":"10.1016\/j.ejmech.2024.116213_bib25","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1021\/op200238p","article-title":"Multkilogram scale-up of a reductive alkylation route to a novel PARP inhibitor","volume":"16","author":"Gillmore","year":"2012","journal-title":"Org. Process Res. Dev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342400093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342400093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:02:29Z","timestamp":1759330949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342400093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"alternative-id":["S022352342400093X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116213","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbazole to indolazepinone scaffold morphing leads to potent cell-active dengue antivirals","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116213"}}